
PD1-PDL1 inhibitor 1
CAS No. 1675201-83-8
PD1-PDL1 inhibitor 1 ( PD-1/PD-L1 inhibitor 1 )
产品货号. M12558 CAS No. 1675201-83-8
PD1-PDL1抑制剂1 (CAS 1675201-83-8)是一种有效的PD-1/PD-L1相互作用抑制剂,在同质时间分辨荧光结合测定中IC50为6-100 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥567 | 有现货 |
![]() ![]() |
5MG | ¥907 | 有现货 |
![]() ![]() |
10MG | ¥1515 | 有现货 |
![]() ![]() |
25MG | ¥2835 | 有现货 |
![]() ![]() |
50MG | ¥4074 | 有现货 |
![]() ![]() |
100MG | ¥5937 | 有现货 |
![]() ![]() |
500MG | ¥12393 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PD1-PDL1 inhibitor 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PD1-PDL1抑制剂1 (CAS 1675201-83-8)是一种有效的PD-1/PD-L1相互作用抑制剂,在同质时间分辨荧光结合测定中IC50为6-100 nM。
-
产品描述PD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
-
体外实验Cell Cytotoxicity Assay Cell Line:NK cells and HepG2 cells Concentration:1 μM Incubation Time:3 days Result:Disturbed the interaction between PD-1 and PD-L1.
-
体内实验Animal Model:BALB/c mice with EMT6 cells Dosage:500 μg/mL; 100 μL Administration:I.p.Result:Increased the survival rates of the mVEGF165b group and mVEGF165b + MUC1 group.mVEGF165b combined with MUC1 results significant retardation of the tumor growth.
-
同义词PD-1/PD-L1 inhibitor 1
-
通路Immunology/Inflammation
-
靶点PD-1/PD-L1
-
受体PD-1/PD-L1
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1675201-83-8
-
分子量475.576
-
分子式C29H33NO5
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 29 mg/mL
-
SMILESO=C([C@H]1N(CC2=C(OC)C=C(OCC3=CC=CC(C4=CC=CC=C4)=C3C)C=C2OC)CCCC1)O
-
化学全称2-Piperidinecarboxylic acid, 1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-, (2S)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Chupak, L.S., and Zheng, X. Compounds useful as immunomodulators. PCT/US2014/053695, (2015).
产品手册




关联产品
-
(D)-PPA 1
PD-1/PD-L1 interaction inhibitor. Binds to PD-L1 (Kd = 0.51 μM). Inhibits interaction at 1 mg/mL in flow cytometry. Inhibits tumor growth and prolongs survival time of mice in vivo.
-
LSD1-IN-24
LSD1-IN-24(compound 3S) 是一种选择性的 LSD1 抑制剂,IC50?= 0.247 μM。LSD1-IN-24 可介导 PD-L1 的表达,增强 T 细胞杀伤反应,可用于癌症研究。
-
Evixapodlin
Evixapodlin (GS-4224) 是一种人 PD-1/PD-L1 蛋白/蛋白相互作用的抑制剂,IC50 为 0.213 nM。Evixapodlin 具有抗癌和抗病毒功能。